Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Allergan plc, a leading global pharmaceutical company, and Naurex Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system, today announced that they have entered into a definitive agreement under which Allergan will acquire Naurex in an all-cash transaction. Under the terms of the agreement, Allergan will acquire Naurex for a $560 million upfront payment net of cash acquired, $460 million of which is payable upon the closing of the acquisition and $100 million of which is payable by January of 2016 (or upon the closing if the closing has not occurred by such time), as well as potential R&D success-based and sales-threshold milestone payments. The Company remains committed to de-leveraging to below 3.5x debt-to-EBITDA by the end of the first quarter of 2016.

  • Schistosomiasis has been found to cause anemia, stunted growth, infertility, liver failure, bladder cancer and lasting cognitive impairment, according to a recent study. Schistosomiasis, a deadly parasitic disease, can be prevented by freshwater prawns. The study, published in the journal Proceedings of the National Academy of Science.

  • Pharma Major Lupin Limited (Lupin) has entered into a strategic asset purchase agreement with TEMMLER PHARMA GMBH & CO. KG (Temmler), a part of the Aenova Group, one of the world’s largest pharmaceutical contract manufacturers, to acquire Temmler's specialty product portfolio subject to certain closing conditions.

  • Parents who force their kids to finish everything served to them may be doing more harm than good, as new research said. In order to promote the development of normal eating behavior, it is important for children to decide how much they want to eat. The findings published in the Journal of Pediatric Psychology

  • Most children with Autism Spectrum Disorder (ASD) suffer from a condition known as macrocephaly in which the head is larger than normal. To get a better understanding of the disorder, the signs of risk and for the development of new drugs, researchers at Yale School of Medicine developed "miniature brains" from skin cells of autistic patients.

    [adsense:336x280:8701650588]

Subscribe to Pharma News